Muscarinic acetylcholine receptor M5
CHRM5 |
|
Identifiers |
Aliases |
CHRM5, HM5, cholinergic receptor muscarinic 5 |
External IDs |
OMIM: 118496 MGI: 109248 HomoloGene: 22697 GeneCards: CHRM5 |
|
Targeted by Drug |
acetylcholine, milameline, pilocarpine, sabcomeline, xanomeline, brucine, VU0238429, AFDX384, amitriptyline, biperiden, darifenacin, glycopyrrolate, hexocyclium, himbacine, methoctramine free base, oxybutynin, pirenzepine, 3-quinuclidinyl-benzilate, tolterodine, |
|
RNA expression pattern |
|
More reference expression data |
Orthologs |
Species |
Human |
Mouse |
Entrez |
|
|
Ensembl |
|
|
UniProt |
|
|
RefSeq (mRNA) |
|
|
RefSeq (protein) |
|
|
Location (UCSC) |
Chr 15: 33.97 – 34.07 Mb |
Chr 2: 112.48 – 112.48 Mb |
PubMed search |
|
|
|
|
1133
213788
ENSG00000184984
ENSMUSG00000074939
P08912
Q920H4
NM_012125
NM_001320917
NM_205783
NP_001307846
NP_036257
NP_991352.2
NP_991352
The human muscarinic acetylcholine receptor M5, encoded by the CHRM5 gene, is a member of the G protein-coupled receptor superfamily of integral membrane proteins. It is coupled to Gq protein. Binding of the endogenous ligand acetylcholine to the M5 receptor triggers a number of cellular responses such as adenylate cyclase inhibition, phosphoinositide degradation, and potassium channel modulation. Muscarinic receptors mediate many of the effects of acetylcholine in the central and peripheral nervous system. The clinical implications of this receptor have not been fully explored; however, stimulation of this receptor is known to effectively decrease cyclic AMP levels and downregulate the activity of protein kinase A (PKA).
...
Wikipedia